What GenieMD does

GenieMD, Inc. is a privately held, founder-led virtual care technology company founded in 2012 and headquartered in the San Francisco Bay Area (Danville/San Ramon, CA). The company operates a white-labeled, HIPAA- and LegitScript-certified platform that combines telehealth (video visits, asynchronous care, built-in EHR and e-prescription via DoseSpot), chronic disease management (RPM/RTM/CCM with cellular monitoring devices and CMS-compliant billing), and a longevity sub-brand called Elora that integrates GRAIL's Galleri multi-cancer early detection test, Prenuvo whole-body MRI, GLP-1 weight-management programs, and biomarker testing. In February 2026, GenieMD launched HelloGenie, a free AI-powered doctor that performs symptom triage and hands off to a nationwide network of board-certified physicians via an affiliated GenieMD Medical Group licensed across all 50 states plus DC.

The platform is supported by a deep integration ecosystem—Dexcom CGM (G5/G6/G7), Quest Diagnostics lab ordering, Zoom video, Voyce interpretation in 240+ languages plus ASL, Stripe payments, and Uber transportation—and recognized with Frost & Sullivan's 2024 Company of the Year Award for virtual chronic disease management. Core customers include hospitals and health systems, ACOs (notably Sunflower ACO via VSM), TPAs and health plans, self-insured employers, pharmacies, pharmaceutical companies, schools, and individual consumers; named enterprise clients include Bronxcare, SureCo, Neurofinity, and A Medical Group.

GenieMD employs 11-50 people and operates a hybrid go-to-market combining enterprise white-label platform licensing and field sales (quote-based multi-year contracts) with direct-to-consumer self-serve telehealth and longevity services (transparent pricing from $99 biomarkers and $125/month GLP-1 memberships up to $2,499 whole-body MRI), a freemium HelloGenie AI acquisition funnel, and B2B2C channel partnerships with pharma and pharmacies. No equity funding rounds or institutional investors are disclosed in the source material, and no revenue figure is publicly reported.

Name

GenieMD

Legal name

GenieMD, Inc.

Website

https://geniemd.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

GenieMD is a privately held virtual care platform company combining white-labeled telehealth, RPM/CCM chronic disease management, and a longevity sub-brand (Elora) with AI-driven triage via its free HelloGenie product, serving hospitals, ACOs, TPAs, employers, and individual consumers across the US.

Ownership category

akta.pro rank

Product category

Virtual Care Platform / Telehealth Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)

akta.pro secondary industries

Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF)

Keywords

• Virtual care platform
• Telehealth solutions
• Chronic care management
• Remote patient monitoring
• AI healthcare assistant

Headquarters

HQ city

Danville, California

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise White-Label Platform Licensing: White-labeled telehealth platform licensing to hospitals, health systems, insurers, and large healthcare organizations. Revenue from setup, customization, and ongoing platform fees.
2. Telehealth Consultation Fees: Direct-to-consumer telehealth consultations with board-certified physicians for individual patients seeking virtual care.
3. CMS Billing (RPM, RTM, CCM, TCM): CMS-compliant billing codes for Remote Patient Monitoring, Remote Therapeutic Monitoring, Chronic Care Management, and Transitions of Care Management services reimbursed by Medicare and Medicaid.
4. Provider Subscription (Concierge): Simple pricing $99 per provider per month for individual providers or clinics using the telehealth platform with interpreter services.
5. Longevity Services: Galleri cancer screening ($799), Whole Body MRI ($999-$2499), biomarkers test ($99), GLP-1 weight loss membership ($125/mo including doctor visit and labs).
6. Pharmaceutical Partnership: Setup charges for pharmaceutical companies promoting products through telemedicine - patients connect to physicians to discuss medications with prescription capability to local pharmacy.
7. Pharmacy Services: Services to pharmacies including medication reconciliation, at-home tests, transportation, and RPM for additional insurance-sponsored income.

Pricing tiers

Go-to-market motion5 records

Distribution channels7 records

Marketing channels6 records

Core offering

GenieMD provides an AI-powered virtual care platform that unifies telehealth, chronic care management (RPM/RTM/CCM), and longevity/preventive health services. It sells a white-label telehealth platform to healthcare enterprises and offers direct-to-consumer telehealth visits, AI-guided health triage (HelloGenie), multi-cancer early detection (Galleri), whole-body MRI (Prenuvo), biomarker testing, and GLP-1 weight loss programs through the Elora sub-brand.

Product overview

GenieMD is an award-winning virtual care technology company offering a modular, white-labeled platform that combines telehealth, chronic disease management, and longevity services. The core platform is the Telehealth Platform (offering video visits, asynchronous care, EHR, e-prescription, and lab integration), augmented by Chronic Disease Management (RPM/RTM/CCM with connected devices and AI alerts), and the Elora longevity sub-brand (Galleri multi-cancer screening, Prenuvo whole-body MRI, GLP-1 weight loss, biomarker testing). HelloGenie serves as the free AI Doctor interface across all services, connecting patients to the GenieMD Medical Group's nationwide network of board-certified physicians. Enterprise-specific modules address Medicare, Medicaid, ACOs, TPAs, hospitals, employers, schools, pharmacies, and pharmaceutical companies. The platform integrates Quest Diagnostics (labs), Dexcom (CGM), Zoom (video), Voyce (interpretation), Stripe (payments), DoseSpot (e-prescription), Uber (transportation), and partner screening tools (Prenuvo MRI, GRAIL Galleri).

Differentiator

Problem solved

Functional benefit

Brands

• Elora: Longevity and preventive health sub-brand offering cancer screening (Galleri), whole-body MRI (via Prenuvo partnership), GLP-1 weight loss medication programs, and biomarker testing.

Products and services

• HelloGenie HelloGenie is a free AI Doctor that processes patient symptom input and delivers structured health guidance while orchestrating handoffs to licensed, board-certified physicians for lab orders, prescriptions, and coordinated follow-up care within GenieMD's connected medical ecosystem. It is intended for individual patients seeking instant health guidance and on-demand physician access.
• Telehealth Platform A white-labeled, HIPAA-compliant telehealth platform for healthcare enterprises (hospitals, health systems, payers, TPAs, ACOs, employers, large group practices) offering branded video visits, asynchronous care, AI-powered patient engagement, secure messaging, scheduling, EHR integration, e-prescription, lab ordering, and native mobile apps.
• Chronic Disease Management (CCM/RPM/RTM) A comprehensive chronic disease management program for healthcare providers, payers, and ACOs that combines Remote Patient Monitoring (RPM), Remote Therapeutic Monitoring (RTM), and Chronic Care Management (CCM) with cellular monitoring devices, AI-driven alerts, care manager outreach, and CMS-compliant billing support for patients with diabetes, hypertension, cardiovascular disease, obesity, respiratory, and behavioral health conditions.
• Elora Elora is GenieMD's longevity and preventive health sub-brand for individual consumers, combining advanced diagnostics, precision medicine, lifestyle optimization, and proactive screening to identify health risks before symptoms appear. It includes multi-cancer early detection, whole-body MRI, advanced biomarkers, genetic insights, ongoing health coaching, and personalized prevention plans.
• Galleri Multi-Cancer Early Detection Test A GRAIL-developed multi-cancer early detection (MCED) blood test offered through GenieMD's Elora program to individual consumers, screening for signals shared by over 50 cancer types via cell-free DNA methylation analysis from a single blood draw at Quest Diagnostics. Recommended for adults 50+ or those with elevated cancer risk, priced at $799.
• Concierge Telehealth A telehealth platform offering for individual providers and private practices delivering secure video, asynchronous and scheduled visits, waiting room, ultra-light patient engagement via SMS link, Quest Diagnostics lab ordering, and e-prescription. Includes interpreter services in 240+ languages, no contract required.

Quantifiable outcome

• 1M+ users worldwide trusting GenieMD for virtual care
• +7 more outcomes

Named customers5 records

Segments10 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability11 records

Feature9 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• PrenuvocoreStrategic or Co-development Partner · 20 November 2025GenieMD partnered with Prenuvo, the leader in whole body MRI for proactive health screening, to bring advanced whole-body MRI screening to patients. Through this partnership, GenieMD customers gain access to Prenuvo's comprehensive whole-body MRI, FDA-cleared AI body composition platform, brain health assessments, and blood biomarkers. Prenuvo has completed 150,000+ scans and operates clinics across major US cities. This partnership reinforces GenieMD's commitment to longevity solutions and deeper health visibility.
• GRAILcoreStrategic or Co-development Partner · 5 November 2025GenieMD integrated GRAIL's groundbreaking Galleri multi-cancer early detection (MCED) test into its personalized longevity and preventive health programs. Galleri screens for 50+ cancer types from a single blood draw with results in ~2 weeks. This partnership empowers clinicians and patients with access to next-generation cancer screening, aligning with GenieMD's mission to extend healthspan through early detection.
• Value Services Management Group (VSM)coreStrategic or Co-development Partner · 19 February 2025GenieMD partnered with Value Services Management Group to provide CCM, Transitions of Care Management (TCM), and Advanced Care Planning services for Sunflower ACO's participating provider organizations. This collaboration aims to improve care coordination, enhance patient engagement, and drive better health outcomes for Medicare beneficiaries in the MSSP Sunflower ACO.
• VoycecoreTechnology or Integration · 4 March 2024GenieMD partnered with Voyce to provide interpretation services in 240+ languages plus American Sign Language (ASL) for virtual care delivery. Voyce delivers simple, seamless, and secure video and audio medical interpreters 24/7. This partnership breaks down language barriers in healthcare, enabling effective communications between care providers and patients from diverse backgrounds.
• DexcomcoreTechnology or IntegrationGenieMD completed integration of Dexcom APIs (version 3) enabling data integration from Dexcom G7, G6, and G5 continuous glucose monitoring devices. Dexcom CGM uses a wearable sensor to continuously measure and send glucose levels. This integration supports RPM and CCM programs for people living with diabetes by consolidating patient data into GenieMD's virtual care platform.
• Quest DiagnosticscoreTechnology or IntegrationSeamless integration with Quest Diagnostics for lab ordering within the GenieMD platform. Patients can access lab orders for Galleri cancer screening, biomarkers testing, and other diagnostics through Quest's nationwide network of lab locations.
• NeurofinityminorOthersHealthcare technology startup utilizing GenieMD's telehealth platform. CEO Raphael Rakowski referenced as customer praising GenieMD's flexibility and value in launching their telehealth program.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• 98point6: 98point6 combines an AI-assisted text-based primary care experience with a nationwide physician network, similar to GenieMD's HelloGenie-to-physician handoff model. Both target self-insured employers and health plans with AI-augmented virtual care.
• Doctor On Demand: Doctor On Demand delivers 24/7 virtual primary care, behavioral health, and chronic condition management to consumers and enterprises. Its integrated virtual care model with physician network parallels GenieMD's HelloGenie + GenieMD Medical Group offering.
• Health Recovery Solutions (HRS): HRS provides RPM and chronic care management platforms with connected devices and clinical workflow tools for hospitals, ACOs, and payers. It is a direct competitor to GenieMD in the cellular-RPM and CCM space targeting the same enterprise customers.
• Amwell: Amwell provides a white-label telehealth platform and chronic care services to health systems, insurers, and employers, closely mirroring GenieMD's enterprise GTM. Both target the same buyers with comparable video-visit, RPM, and EHR-integrated virtual care offerings.
• Teladoc Health: Teladoc Health is the largest publicly traded virtual care platform, offering telehealth, chronic condition management, and AI-enabled primary care to enterprises, payers, and consumers. It competes head-to-head with GenieMD across the same white-label telehealth, RPM/CCM, and integrated care segments.
• Included Health: Included Health offers integrated virtual primary care, behavioral health, and care navigation for employers and payers. Its combination of AI triage, physician network, and chronic care support is structurally similar to GenieMD's unified virtual care platform.
• MDLive (Cigna's Evernorth): MDLive, part of Evernorth/Cigna, offers virtual primary care, behavioral health, and dermatology visits to consumers and enterprise clients. It competes with GenieMD's telehealth platform across the same buyer segments and chronic care use cases.
• Vivify Health: Vivify Health specializes in remote patient monitoring and chronic care management with cellular-connected devices and AI-driven workflows. Its RPM/CCM focus and CMS-compliant billing model directly overlap GenieMD's chronic disease management product.

Emerging players

• K Health: K Health provides AI-driven primary care and chronic condition management to consumers and payers. While its consumer-first go-to-market differs, its AI-triage + physician model overlaps GenieMD's HelloGenie approach in primary care and cardiometabolic conditions.
• TytoCare: TytoCare provides connected remote examination devices and a telehealth platform for health systems and payers. Its device-plus-platform approach overlaps with GenieMD's cellular-RPM device strategy for chronic condition management.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/geniemd
• Facebookfacebook.com/contactGenieMD
• LinkedInlinkedin.com/company/geniemd
• Instagraminstagram.com/geniemd_telehealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenieMD